During the past decade, University Hospital Mannheim conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 11 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Mannheim" #1 sponsor was "Universitätsmedizin Mannheim" with 18 trials, followed by "Heidelberg University" with 11 trials sponsored, "Incyte Corporation" with 5 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored and "Guerbet" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Mannheim" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Hannover Medical School" with 2 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials as a collaborator, "Medical University Innsbruck" with 2 trials as a collaborator and "Medical University of Vienna" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Mannheim" are "Heart Failure" (3 trials), "Invasive Aspergillosis" (3 trials), "Sepsis" (3 trials), "Septic Shock" (3 trials) and "Severe Sepsis" (3 trials). Many other conditions were trialed in "University Hospital Mannheim" in a lesser frequency.

Most popular intervention types in "University Hospital Mannheim" are "Drug" (34 trials), "Device" (7 trials), "Procedure" (6 trials), "Other" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pemigatinib" (2 trials), "5-Fluorouracil" (1 trials), "5-Fluorouracil during radiotherapy" (1 trials) and "AG013" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Mannheim" are 65 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Mannheim". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in University Hospital Mannheim, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Mannheim, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".